Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» epilepsy
epilepsy
Stoke faces new doubts in search for ‘Spinraza for epilepsy’
Stoke faces new doubts in search for ‘Spinraza for epilepsy’
BioPharma Dive
Stoke Therapeutics
Dravet syndrome
epilepsy
STK-001
Flag link:
Neurona’s brain stem cell therapy shows early efficacy in epilepsy
Neurona’s brain stem cell therapy shows early efficacy in epilepsy
Clinical Trials Arena
Neurona
stem cells
epilepsy
clinical trials
Flag link:
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
Flag link:
With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst
With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst
Fierce Pharma
Eisai
Fycompa
Catalyst Pharmaceuticals
epilepsy
Flag link:
Praxis ends year on high with $100M biobucks UCB deal for epilepsy medicine
Praxis ends year on high with $100M biobucks UCB deal for epilepsy medicine
Fierce Biotech
Praxis
UCB Pharma
epilepsy
PRAX-020
Flag link:
Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite
Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite
Fierce Biotech
Biohaven
Pfizer
funding
epilepsy
Flag link:
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Pfizer
Biohaven
migraines
epilepsy
Flag link:
Ovid takes a novel approach to gene therapy
Ovid takes a novel approach to gene therapy
EP Vantage
Ovid Therapeutics
gene therapy
epilepsy
phages
Flag link:
Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial
Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial
BioSpace
Jazz Pharma
Epidiolex
clinical trials
pediatrics
epilepsy
cannabindoids
Flag link:
After rejection, Azurity gets FDA nod for liquid epilepsy drug
After rejection, Azurity gets FDA nod for liquid epilepsy drug
Fierce Pharma
Azurity
FDA
zonisamide
epilepsy
Flag link:
French court rules against Sanofi in landmark Depakine case
French court rules against Sanofi in landmark Depakine case
Endpoints
legal
Sanofi
France
Depakine
epilepsy
birth defects
pregnancy
Flag link:
FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug
FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug
Endpoints
Praxis Precision Medicines
FDA
clinical hold
epilepsy
PRAX-222
Flag link:
Controversial opioid Zohydro ER pulled from the market
Controversial opioid Zohydro ER pulled from the market
Endpoints
UCB Pharma
epilepsy
Zogenix
Zohydro ER
Flag link:
Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline
Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline
Pharmaceutical Business Review
Ovid Therapeutics
AstraZeneca
small molecule drugs
epilepsy
Flag link:
Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy
Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy
Endpoints
Xenon
epilepsy
XEN-1101
clinical trials
Flag link:
Neuroelectrics gets $17M for new take on electrical therapy for epilepsy, depression
Neuroelectrics gets $17M for new take on electrical therapy for epilepsy, depression
MedCity News
Neuroelectrics
electrical therapy
devices
wearables
funding
epilepsy
Flag link:
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Stat
Jazz Pharma
GW Pharma
M&A
CBD
epilepsy
Epidiolex
Flag link:
UCB backs epilepsy-focused digital heath startup Nile AI
UCB backs epilepsy-focused digital heath startup Nile AI
Pharmaforum
UCB Pharma
digital health
Nile AI
artificial intelligence
epilepsy
Flag link:
In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
Endpoints
Arvelle Therapeutics
Angelini Pharma
M&A
CNS
epilepsy
cenobamate
Axovant
Flag link:
Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy
Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy
Pharmaceutical Business Review
Cerebral Therapeutics
clinical trials
CT-010
epilepsy
Flag link:
Pages
1
2
3
4
5
6
7
8
9
next ›
last »